$48.770
-1.975 (-4.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
RAPP Prediction & Forecast by Similar Chart Analysis
Alphio's RAPP stock price prediction model matches the current Rapport Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $48.43 (-0.69%). The 1-week path is $48.42 (-0.72%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Rapport Therapeutics Inc Stock?
Rapport Therapeutics Inc is a good buy right now due to its recent strong performance, with a current price of $48.77, and a significant year-to-date change of +73.50%. The company's gross margin has improved to 100% in Q1 2026, indicating a strong potential for profitability as it advances its therapies. Additionally, analysts have set price targets as high as $79.03, suggesting substantial upside from the current price. However, a risk to consider is the recent widening net loss of $56.6 million in Q2 2026, which could impact investor sentiment.
RAPP stock price ended at $48.77 on Friday, after losing -4.05%
Rapport Therapeutics Inc (RAPP) last closed at $48.77, losing -4.05%. These facts feed the 1-day and 1-week RAPP price prediction above.
Forecast Drivers
Rapport Therapeutics Inc (RAPP) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches RAPP, ranked by similarity.
Seasonality analysis for RAPP
Historically the probability of a positive August return for RAPP is 47.62%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for RAPP
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $13.60 | $15.67 | $17.33 | -67.87% |
| Sep 2026 | $15.49 | $17.38 | $18.58 | -64.36% |
| Oct 2026 | $11.59 | $13.51 | $13.94 | -72.30% |
| Nov 2026 | $13.96 | $15.06 | $17.94 | -69.13% |
| Dec 2026 | $13.60 | $15.18 | $17.69 | -68.87% |
In 2026, Rapport Therapeutics Inc (RAPP) is projected to range from $11.59 to $18.58.
Rapport Therapeutics Inc 2026 monthly forecast
In Aug 2026, Rapport Therapeutics Inc is projected to average $15.67, with a low of $13.60 and high of $17.33.
In Sep 2026, Rapport Therapeutics Inc is projected to average $17.38, with a low of $15.49 and high of $18.58.
In Oct 2026, Rapport Therapeutics Inc is projected to average $13.51, with a low of $11.59 and high of $13.94.
In Nov 2026, Rapport Therapeutics Inc is projected to average $15.06, with a low of $13.96 and high of $17.94.
In Dec 2026, Rapport Therapeutics Inc is projected to average $15.18, with a low of $13.60 and high of $17.69.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.